Persee Medica Report issue

For profit
Founded: bailly France (1985)
Status: No NME R&D (1985)

Organization Overview

First Clinical Trial
2006
NCT00484497
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (1)

cyclamax (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1